Clinical trials

Clinical trials are an important part of the process of developing new medicines for patients. A type of scientific research study, they explore whether a potential new medicine is safe to use and will work as intended in humans. Those who choose to participate in clinical trials are an important part of vital research that could change the course of disease and help improve lives.

Our clinical trials in

Huntington’s disease

Our clinical trials in

Huntington’s disease

Trial
Recruiting

We are currently recruiting adults with early manifest Huntington’s disease (HD) who carry a SNP at the rs362307 (“SNP1”) location for a Phase 1b/2a clinical trial.

Learn more about Wave trials for HD at clinicaltrials.gov

Trial
Recruiting

We are currently recruiting adults with early manifest Huntington’s disease (HD) who carry a SNP at the rs362331 (“SNP2”) location for a Phase 1b/2a clinical trial.

Learn more about Wave trials for HD at clinicaltrials.gov

Our clinical trials in

Amyotrophic lateral sclerosis

Our clinical trials in

Amyotrophic lateral sclerosis

Trial in
Development

We anticipate initiating a trial for our amyotrophic lateral sclerosis (ALS) program.

Learn more about Wave trials for ALS by contacting [email protected]

Our clinical trials in

Frontotemporal dementia

Our clinical trials in

Frontotemporal dementia

Trial in
Development

We anticipate initiating a trial for our frontotemporal dementia (FTD) program.

Learn more about Wave trials for FTD by contacting [email protected]